Loading...
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease
OBJECTIVE: To test the hypothesis that chronic treatment of early-stage Huntington disease (HD) with high-dose coenzyme Q10 (CoQ) will slow the progressive functional decline of HD. METHODS: We performed a multicenter randomized, double-blind, placebo-controlled trial. Patients with early-stage HD (...
Na minha lista:
| Udgivet i: | Neurology |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Lippincott Williams & Wilkins
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5224719/ https://ncbi.nlm.nih.gov/pubmed/27913695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000003478 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|